Polaris Group (TPE:6550)
Taiwan · Delayed Price · Currency is TWD 35.50
-0.40 (-1.11%)
Oct 7, 2025, 9:40 AM CST
Polaris Group Market Cap
Polaris Group has a market cap or net worth of 27.66 billion as of October 6, 2025. Its market cap has decreased by -36.16% in one year.
Market Cap
27.66B
Enterprise Value
29.78B
Revenue
64.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
35.50
Market Cap Chart
Since February 15, 2016, Polaris Group's market cap has decreased from 46.46B to 27.66B, a decrease of -40.46%. That is a compound annual growth rate of -5.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 27.66B | -18.80% |
| Dec 31, 2024 | 34.06B | -39.39% |
| Dec 29, 2023 | 56.21B | -14.57% |
| Dec 30, 2022 | 65.79B | 24.20% |
| Dec 30, 2021 | 52.97B | 373.09% |
| Dec 31, 2020 | 11.20B | -8.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 276.86B |
| PharmaEssentia | 206.74B |
| Bora Pharmaceuticals Co., LTD. | 85.39B |
| Lotus Pharmaceutical | 69.95B |
| Lumosa Therapeutics | 49.53B |
| Oneness Biotech | 31.18B |
| Center Laboratories | 26.65B |
| Pegavision | 24.73B |